Boston Scientific (BSX) Operating Expenses (2009 - 2026)

Boston Scientific has disclosed Operating Expenses across 18 years of filings, most recently posting $2.7 billion for Q2 2026.

• In Q2 2026, Operating Expenses rose 2.5% year-over-year to $2.7 billion; the TTM figure through Jun 2026 stood at $10.5 billion (up 11.12% YoY), while the FY2025 annual figure was $10.2 billion, up 15.24% from the prior year.
• Operating Expenses came in at $2.7 billion for Q2 2026 at Boston Scientific, up from $2.5 billion in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $2.9 billion in Q4 2025 to a low of $1.6 billion in Q1 2022.
• Average Operating Expenses over 5 years is $2.2 billion, with a median of $2.1 billion recorded in 2023.
• Year-over-year, Operating Expenses dropped 7.34% in 2022 and advanced 24.87% in 2024.
• Over 5 years, Operating Expenses stood at $1.8 billion in 2022, then grew by 9.02% to $2.0 billion in 2023, then climbed by 21.3% to $2.4 billion in 2024, then increased by 17.93% to $2.9 billion in 2025, then fell by 6.45% to $2.7 billion in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $2.7 billion in Q2 2026, $2.5 billion in Q1 2026, and $2.9 billion in Q4 2025.